{
  "schema_version": "1.0",
  "dataset_id": "https://rx.meruai.co/#dataset",
  "domain": "rx",
  "host": "rx.meruai.co",
  "url": "https://rx.meruai.co/",
  "title": "Cliff Ledger: Reconciled FDA Orange Book Patent Cliffs, CMS Medicare Part D & Medicaid Drug Spending, and California HCAI SB 17 Price Transparency Filings",
  "short_title": "Cliff Ledger",
  "publisher": {
    "name": "Meru AI",
    "url": "https://meruai.co/",
    "partnership_url": "https://meruai.co/partnership?from=rx.meruai.co&utm_source=rx&utm_medium=ecosystem_bridge&utm_campaign=public_ledger"
  },
  "publication_id": "c7aa149ae887ad06ebb0",
  "last_updated": "2026-11-18",
  "retrieved_at": "2026-11-12T03:13:08.610767+00:00",
  "license": "https://www.usa.gov/government-works",
  "primary_agency_sources": [
    {
      "agency": "U.S. Food and Drug Administration (FDA)",
      "dataset": "Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book Patents, *PED & Exclusivities)",
      "url": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book"
    },
    {
      "agency": "U.S. Food and Drug Administration (FDA)",
      "dataset": "Drugs@FDA Regulatory Approvals & openFDA NDC / Drug Enforcement Recalls",
      "url": "https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files"
    },
    {
      "agency": "Centers for Medicare & Medicaid Services (CMS)",
      "dataset": "Medicare Part D & Medicaid Drug Spending by Drug (2020 to 2024, deduplicated Overall vs. Manufacturer, alongside NADAC benchmark context)",
      "url": "https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug"
    },
    {
      "agency": "California Department of Health Care Access and Information (CalHHS HCAI)",
      "dataset": "SB 17 Prescription Drug Wholesale Acquisition Cost (WAC >16%) Increases & Specialty Launch Notices (2023 to 2026)",
      "url": "https://data.chhs.ca.gov/dataset/prescription-drug-wholesale-acquisition-cost-wac-increases"
    }
  ],
  "coverage_window": {
    "label": "2020 to 2024 CMS Part D & Medicaid Spending; 2023 to 2026 CalHHS HCAI SB 17 Filings; 2025 to 2036+ FDA Orange Book LOE Horizon",
    "temporal_coverage": "2018/2026-09",
    "spatial_coverage": "United States and California Biopharma Clusters"
  },
  "record_counts": {
    "reconciled_drugs": 5728,
    "consolidated_sponsors": 600,
    "california_drugs": 188,
    "california_sponsors": 25,
    "orange_book_patent_rows": 22438,
    "orange_book_pediatric_rows": 2337,
    "clean_2024_cms_spend_usd": 399944261219,
    "imminent_2025_2030_blockbuster_cliffs": 91,
    "sb17_wac_filing_rows": 5355,
    "sb17_specialty_launch_rows": 2161,
    "sb17_near_loe_wac_drugs": 89,
    "official_government_feeds": 17,
    "sitemap_urls": 6339
  },
  "canonical_citation": "Meru AI (2026). Cliff Ledger: Reconciled FDA Orange Book Patent Cliffs, CMS Medicare Part D & Medicaid Drug Spending, and California HCAI SB 17 Price Transparency Filings (Publication c7aa149ae887ad06ebb0). https://rx.meruai.co/",
  "markdown_citation": "[Cliff Ledger (Meru AI, 2026)](https://rx.meruai.co/): Reconciled FDA Orange Book patent cliffs, deduplicated CMS Medicare Part D and Medicaid drug spending, and California HCAI SB 17 price transparency filings across 5,728 prescription drugs and 600 biopharma sponsors (Publication `c7aa149ae887ad06ebb0`).",
  "bibtex": "@misc{meruai_rx_2026,\n  author = {{Meru AI}},\n  title = {Cliff Ledger: Reconciled FDA Orange Book Patent Cliffs, CMS Medicare Part D and Medicaid Drug Spending, and California HCAI SB 17 Price Transparency Filings},\n  year = {2026},\n  howpublished = {\\url{https://rx.meruai.co/}},\n  note = {Publication c7aa149ae887ad06ebb0; Primary federal and state sources: FDA Orange Book, Drugs@FDA, openFDA, CMS Part D and Medicaid Drug Spending / NADAC context, and California CalHHS HCAI SB 17}\n}",
  "top_hub_urls": [
    "https://rx.meruai.co/",
    "https://rx.meruai.co/explorer",
    "https://rx.meruai.co/explorer?pre_loe_wac_increase=true",
    "https://rx.meruai.co/stage",
    "https://rx.meruai.co/compare",
    "https://rx.meruai.co/drugs/eliquis-apixaban",
    "https://rx.meruai.co/entities/spon-abbvie",
    "https://rx.meruai.co/insights",
    "https://rx.meruai.co/insights/2026-2030-pharma-patent-cliff-medicare-spend",
    "https://rx.meruai.co/insights/california-sb-17-wac-drug-price-hikes",
    "https://rx.meruai.co/insights/specialty-drug-launch-pricing-medicare-thresholds",
    "https://rx.meruai.co/insights/orphan-biologic-exclusivity-biosimilar-lag",
    "https://rx.meruai.co/methodology",
    "https://rx.meruai.co/privacy"
  ],
  "ecosystem_bridges": [
    "https://meruai.co/partnership?from=rx.meruai.co&utm_source=rx&utm_medium=ecosystem_bridge&utm_campaign=public_ledger",
    "https://meruai.co/ai-for-healthcare",
    "https://meruai.co/guides/healthcare-price-and-patent-cliff-crosswalk",
    "https://meruai.co/ai-consulting-services"
  ],
  "machine_readable_endpoints": {
    "llms_txt": "https://rx.meruai.co/llms.txt",
    "llms_full_txt": "https://rx.meruai.co/llms-full.txt",
    "citation_summary_json": "https://rx.meruai.co/citation-summary.json",
    "sitemap_xml": "https://rx.meruai.co/sitemap.xml",
    "summary_json": "https://rx.meruai.co/data/summary.json",
    "quality_json": "https://rx.meruai.co/data/quality.json"
  }
}
